Choice at LSI Barcelona '23
Our Co-Founder & CCA Leonie van de Kamer starring at the LSI Event in Barcelona last September!
In the picture she is showing the world's smallest endoscope developed together with OptaSensor GmbH to enhance placement of the Choice devices in the fallopian tubes and to prevent adverse events during placement.
Inside human fallopian tubes
What we did with the sheep & cow fallopian tubes, we repeated inside human fallopian tubes. Marlies Bongers & Bas Veersema, our gynaecologists from our Board of Advice went inside two just removed uterusses. We learned a lot, but unfortunately after the session our images were corrupted #$@!!. The ampulla, where fertilization takes place & so we have all began, looks pretty similar as the previous video of a sheep's ampulla. We will do this again!
Inside bovine/sheep fallopian tubes
With our newly developed tools we are exploring where all of us began...Together with the UMC professors Bas Veersema (Gynaecology) & Peter Vos (Veterinary Medicine) we looked inside cow & sheep fallopian tubes (this is a sheep). Human fallopian tubes to follow soon.
Choice discussed with Egyptian femal students
Peter van de Graaf presented Choice to some 100 female students at Sohag University, followed by a lively discussion. Overall outcome was that most students considered Choice excellent contraception for themselves and Egypt in general, as we have found elsewhere. We must reach the poor, whose needs are highest because of their large families, leading to rapid population increase in Egypt. For this Choice will need social workers for outreach, and, most important, Choice needs to be affordable.
With regard to cultural issues: the family planning decisions are not an individual decision, but take place within the (extended) family, and because sterilization is religiously contentious it should not be labelled "reversible sterilization".
Thanks a bundle to Sohag University, Laila El-Sayed & my brother in law Samir Khalifa for making this extraordinary and interesting session possible.
CHOICE obtains ISO13485 Certificate
We are happy to announce that we successfully passed our first ISO 13485 audit. This will lead to a ISO certification expected Q1 2023. This is an important step for Choice as this ISO certificate will help us grow within the medical device business (work together with suppliers and eventually customers) and will help the company to maintain a solid and respected quality management system from design and development stages until post-marketing.
July 2022 Peter and Leonie did an interview for M&A magazine. They explain about our 'passion proof' contraception, organoidstudies, funding, the origin of Choice and Choice's future.
Interview Money Meets Ideas
In 2022 pitchte Peter van de Graaf - CEO van Choice - zijn kapitaalbehoefte aan de formal investors van Money Meets Ideas. Via de bijeenkomst kwam hij in contact met meerdere informal investors. Na gesprekken met deze informals vond Peter een passende match en kwamen zij tot een deal. Met de investering kan Choice de unieke anticonceptie technologie verder doorontwikkelen.
DAMN HONEY podcast
Choice is mentioned in episode 91 (April 2022) of the DAMN HONEY podcast. This podcast is a weekly podcast to honour the female body. In episode 91 Prof. Dr. Marlies Bongers speaks about futuristic solutions for contraceptives. Choice is mentioned from minute 21:45 onwards.
You can listen the podcast in Dutch on Spotify or iTunes.
Choice is starring in this video by Brainport Eindhoven about three pioneer start-ups in MedTech (April 2022).
Brabant Startup Fund
Choice features in the promovideo for the Brabant Startup Fund (November 2021).
TedX Talks Maastricht
CEO Peter van de Graaf explains why we need a worl where every child is desired (July 2020)